Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $15.4 million.

  • Biofrontera's Liabilities and Shareholders Equity fell 1674.77% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.2 million, marking a year-over-year decrease of 1981.81%. This contributed to the annual value of $22.1 million for FY2024, which is 2087.57% down from last year.
  • As of Q3 2025, Biofrontera's Liabilities and Shareholders Equity stood at $15.4 million, which was down 1674.77% from $20.1 million recorded in Q2 2025.
  • Biofrontera's Liabilities and Shareholders Equity's 5-year high stood at $55.1 million during Q3 2022, with a 5-year trough of $15.4 million in Q3 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $26.3 million (2023), whereas its average is $32.5 million.
  • Per our database at Business Quant, Biofrontera's Liabilities and Shareholders Equity soared by 25859.71% in 2022 and then crashed by 4570.72% in 2024.
  • Over the past 5 years, Biofrontera's Liabilities and Shareholders Equity (Quarter) stood at $53.2 million in 2021, then dropped by 4.39% to $50.9 million in 2022, then tumbled by 45.11% to $27.9 million in 2023, then fell by 20.88% to $22.1 million in 2024, then plummeted by 30.25% to $15.4 million in 2025.
  • Its Liabilities and Shareholders Equity was $15.4 million in Q3 2025, compared to $20.1 million in Q2 2025 and $16.6 million in Q1 2025.